NOVEMBER 17, 2008 -- The U.S. Food and Drug Administration (FDA) has cleared LED Technologies' (Elizabeth, CO) DPL (Deep Penetrating Light) Therapy System for home use for pain relief. The system enables noninvasive, non-drug application for the relaxation of muscles and relief of muscle spasms, temporary relief of minor muscle and joint aches, pains and stiffness; temporary relief of minor pain and stiffness associated with arthritis; and temporarily increases local blood circulation. This clearance opens the way for the DPL Therapy System to bring temporary pain relief technology directly to the consumer without a prescription.
"This FDA clearance marks a considerable landmark for our company as we demonstrate our leadership in LED light-based science and develop innovative LED applications for the medical, professional and home use markets," commented Brent Safer, Director of Operations and designer of the system.
The future of the DPL Therapy System is extremely bright, says the company, as its applications expand beyond the minor pain relief field. Currently, LED Technologies, LLC is developing new DPLtreatments for wrinkle reduction, TMJ, Fibromyalgia, Acne and a variety of other pain and wound healing applications.
"LED Technologies, LLC is committed to being the leader in LED light based therapy by bringing new and affordable medical applications to the consumer marketplace," stated Ron Ferguson Director of Sales and Marketing for the company. "Our research shows great demand for effective and affordable medical applications that the individual can use in the privacy of their own homes."
LED Technologies, LLC